Insight Guide

What’s Next for mRNA?

Format: PDF file | Document type: Insight Guide | Promoted Content

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of

What’s Next for mRNA?

Now that the pharma industry and regulators have significant data on safety and efficacy of mRNA vaccines, many companies are looking beyond infectious disease to potentially develop therapies for a variety of indications. In this Q&A, a Catalent Biologics expert addresses the challenges of mRNA development and manufacturing, potential solutions & the future of mRNA in industry. 

Latest content from Catalent

Related resources from Catalent

Show more

Supplier info centre